Jansing R L, Chao E S, Kaminsky L S
Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201-0509.
Mol Pharmacol. 1992 Jan;41(1):209-15.
We used adult rat hepatocytes in primary culture (HPC) as a model system to study the hepatic phase II metabolism of the anticoagulant warfarin. Hepatocytes were isolated by a collagenase perfusion technique and maintained for 24 hr in Waymouth's medium containing 0.1 mM (R)-warfarin. When HPC medium was analyzed by reverse phase high performance liquid chromatography with diode-array detection, 4'-, 6-, and 7-hydroxywarfarin were identified. Several putative conjugates were observed eluting between 13 and 18 min. Treatment of hepatocyte medium with beta-glucuronidase and sulfatase resulted in the loss of five putative conjugates and concomitant increases in 4'-, 6-, and 7-hydroxywarfarin and warfarin, suggesting that these metabolites and warfarin were conjugated. Use of the beta-glucuronidase inhibitor saccharic acid 1,4-lactone enabled the determination of the relative extents of conjugation of each metabolite by glucuronic acid and sulfate. Glucuronidation was the predominant pathway for 4'-hydroxywarfarin, whereas 6-hydroxywarfarin and warfarin occurred mainly as sulfate conjugates. In contrast, 7-hydroxywarfarin was converted to both glucuronide and sulfate conjugates. Exposure of HPC to phenobarbital resulted in a decrease in cytochrome P-450-mediated production of hydroxylated warfarin metabolites; however, an increase in the production of 8-hydroxywarfarin was observed when HPC were exposed to beta-naphthoflavone. Unique conjugation patterns were found when hydroxylated warfarins were substituted for warfarin in HPC medium. Both 7- and 8-hydroxywarfarin were converted to one sulfate and two glucuronide conjugates, whereas 4'-hydroxywarfarin was converted to a single glucuronide conjugate. A spectral library of these conjugates was used to identify the major conjugates of warfarin formed by rat HPC.
我们使用原代培养的成年大鼠肝细胞(HPC)作为模型系统,研究抗凝血剂华法林的肝脏II相代谢。通过胶原酶灌注技术分离肝细胞,并在含有0.1 mM(R)-华法林的Waymouth培养基中维持24小时。当用带二极管阵列检测的反相高效液相色谱分析HPC培养基时,鉴定出了4'-、6-和7-羟基华法林。观察到几个假定的共轭物在13至18分钟之间洗脱。用β-葡萄糖醛酸酶和硫酸酯酶处理肝细胞培养基导致五个假定的共轭物消失,同时4'-、6-和7-羟基华法林以及华法林增加,这表明这些代谢物和华法林是共轭的。使用β-葡萄糖醛酸酶抑制剂糖二酸1,4-内酯能够确定每种代谢物与葡萄糖醛酸和硫酸盐的共轭相对程度。葡萄糖醛酸化是4'-羟基华法林代谢的主要途径,而6-羟基华法林和华法林主要以硫酸盐共轭物形式存在。相比之下,7-羟基华法林转化为葡萄糖醛酸和硫酸盐共轭物。HPC暴露于苯巴比妥会导致细胞色素P-450介导的羟基化华法林代谢物生成减少;然而,当HPC暴露于β-萘黄酮时,观察到8-羟基华法林生成增加。当在HPC培养基中用羟基化华法林替代华法林时,发现了独特的共轭模式。7-和8-羟基华法林都转化为一种硫酸盐和两种葡萄糖醛酸共轭物,而4'-羟基华法林转化为单一的葡萄糖醛酸共轭物。这些共轭物的光谱库用于鉴定大鼠HPC形成的华法林主要共轭物。